住友化学 Remeasurements Of Defined Benefit Plans、投資有価証券売却益、Increase In Property Plant And Equipment And Intangible Assets - Pharmaceuticals Reportable Segments Member他2件
Remeasurements Of Defined Benefit Plans、投資有価証券売却益、Increase In Property Plant And Equipment And Intangible Assets - Pharmaceuticals Reportable Segments Member他2件 【期間】 年度 Remeasurements Of Defined Benefit Plans 投資有価証券売却益 Increase In Property Plant And Equipment And Intangible Assets - Pharmaceuticals Reportable Segments Member Non Controlling Interests Financial Liabilities At Fair Value Through Profit Or Loss Interest ExpensesIFRS 2015/06 - 60.1億 - - - 2017/06 - 34.1億 -43.1% - - -
勘定科目を追加して比較 